Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis

Ronchi, 2019, Extragonadal germ cell tumors: not just a matter of location. A review about clinical, molecular and pathological features, Cancer Med, 8, 6832, 10.1002/cam4.2195 Pekmezi, 2011, Updated evidence in support of diet and exercise interventions in cancer survivors, Acta Oncol, 50, 167, 10.3109/0284186X.2010.529822 Geiger, 2011, Delineating the age ranges used to define adolescents and young adults, J Clin Oncol, 29, 10.1200/JCO.2011.35.5602 Schneider, 2004, Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols, Pediatr Blood Cancer, 42, 169, 10.1002/pbc.10321 Feldman, 2009, Good-risk-advanced germ cell tumors: historical perspective and current standards of care, World J Urol, 27, 463, 10.1007/s00345-009-0431-z de Wit, 2007, Refining the optimal chemotherapy regimen in good prognosis germ cell cancer: interpretation of the current body of knowledge, J Clin Oncol, 25, 4346, 10.1200/JCO.2007.13.3777 Kondagunta, 2005, Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors, J Clin Oncol, 23, 6549, 10.1200/JCO.2005.19.638 Kondagunta, 2007, Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors, J Clin Oncol, 25, 85, 10.1200/JCO.2006.06.9401 Kier, 2016, Second malignant neoplasms and cause of death in patients with germ cell cancer: a Danish nationwide cohort study, JAMA Oncol, 2, 1624, 10.1001/jamaoncol.2016.3651 Travis, 2005, Second cancers among 40,576 testicular cancer patients: focus on long-term survivors, J Natl Cancer Inst, 97, 1354, 10.1093/jnci/dji278 Hartmann, 2000, Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors, J Natl Cancer Inst, 92, 54, 10.1093/jnci/92.1.54 Hauptmann, 2015, Increased stomach cancer risk following radiotherapy for testicular cancer, Br J Cancer, 112, 44, 10.1038/bjc.2014.552 Horwich, 2014, Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma, Br J Cancer, 110, 256, 10.1038/bjc.2013.551 Miller, 2017, Age >/=40 years is associated with adverse outcome in metastatic germ cell cancer despite appropriate intended chemotherapy, Eur Urol Focus, 3, 621, 10.1016/j.euf.2016.10.005 Rivera, 2010, Prognostic factors in patients with primary mediastinal germ cell tumors, a surgical multicenter retrospective study, Interact Cardiovasc Thorac Surg, 11, 585, 10.1510/icvts.2010.238717 Thomsen, 2014, Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older, Cancer, 120, 43, 10.1002/cncr.28374 1997, International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers., J Clin Oncol, 15, 594, 10.1200/JCO.1997.15.2.594 Serdar, 2015, Adjuvant radiotherapy in stage 1 seminoma: evaluation of prognostic factors and results of survival, J Cancer Res Ther, 11, 313, 10.4103/0973-1482.140846 Kollmannsberger, 1998, Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors, J Clin Oncol, 16, 3386, 10.1200/JCO.1998.16.10.3386 Honecker, 2018, ESMO consensus conference on testicular germ cell cancer: diagnosis, treatment and follow-up, Ann Oncol, 29, 1658, 10.1093/annonc/mdy217 Howard, 2008, Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients, Ann Epidemiol, 18, 416, 10.1016/j.annepidem.2008.01.003 Lorch, 2014, A practice-changing step forward in germ-cell cancer, Lancet Oncol, 15, 1409, 10.1016/S1470-2045(14)71103-9 Zequi Sde, 2012, Bilateral testicular germ cell tumours: a systematic review, BJU Int, 110, 1102, 10.1111/j.1464-410X.2012.11056.x Hemminki, 2010, Second cancers after testicular cancer diagnosed after 1980 in Sweden, Ann Oncol, 21, 1546, 10.1093/annonc/mdp562 Ruf, 2015, Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia, Andrology, 3, 92, 10.1111/j.2047-2927.2014.00260.x Dieckmann, 2007, Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy, Eur Urol, 51, 175, 10.1016/j.eururo.2006.05.051 Kier, 2015, Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study, Ann Oncol, 26, 737, 10.1093/annonc/mdu585 Kliesch, 2003, Update on the diagnostic safety for detection of testicular intraepithelial neoplasia (TIN), APMIS, 111, 70, 10.1034/j.1600-0463.2003.11101101.x Holstein, 1996, Histologic diagnostics of early testicular germ-cell tumor, Int J Urol, 3, 165, 10.1111/j.1442-2042.1996.tb00507.x Rud, 2013, Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer, J Urol, 190, 2074, 10.1016/j.juro.2013.06.023 Noone, 2016, Comparison of SEER treatment data with Medicare claims, Med Care, 54, e55, 10.1097/MLR.0000000000000073